Bausch & Lomb BLCO
NYSE BLCO
$17.56 -0.23 (-1.29%)
As of: Sep 10, 2026 · 3:59 PM EDT

Bausch & Lomb (BLCO) Non-Current Deferred Tax Liability (2021 - 2026)

Bausch & Lomb's (BLCO) quarterly Non-Current Deferred Tax Liability came in at $18.0 million in Q2 2026, up 28.57% on a YoY basis from $14.0 million in Q2 2025, and down 5.26% quarter-over-quarter from $19.0 million in Q1 2026.

Analysis

Bausch & Lomb (BLCO) Non-Current Deferred Tax Liability (2021 - 2026) Analysis & Trends

Bausch & Lomb (BLCO) has reported Non-Current Deferred Tax Liability for 6 consecutive years, with $18.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Non-Current Deferred Tax Liability rose 28.57% year-over-year to $18.0 million; the trailing twelve-month figure through Jun 2026 stood at $18.0 million (up 28.57% YoY), and the FY2025 full-year result was $19.0 million, down 83.62% from the prior year.
  • Non-Current Deferred Tax Liability declined to $18.0 million in Q2 2026 per BLCO's latest filing, from $19.0 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $118.0 million in Q4 2023 and bottomed at $10.0 million in Q2 2022.
  • Historically, Non-Current Deferred Tax Liability has averaged $36.1 million across 5 years, with a median of $14.0 million in 2023.
  • The sharpest annual moves came in 2022 and 2023: Non-Current Deferred Tax Liability jumped 120.75% in 2022, then tumbled 86.41% in 2023.
  • Over 5 years, Non-Current Deferred Tax Liability stood at $117.0 million in 2022, then grew by 0.85% to $118.0 million in 2023, then declined by 1.69% to $116.0 million in 2024, then plunged by 83.62% to $19.0 million in 2025, then dropped by 5.26% to $18.0 million in 2026.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $18.0 million, $19.0 million, and $19.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn
10 Bausch & Lomb 6.28 Bn 5.90 Bn 867.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.00 Mn
Mar 31, 2026 19.00 Mn
Dec 31, 2025 19.00 Mn
Sep 30, 2025 14.00 Mn
Jun 30, 2025 14.00 Mn
Mar 31, 2025 13.00 Mn
Dec 31, 2024 116.00 Mn
Sep 30, 2024 12.00 Mn
Jun 30, 2024 14.00 Mn
Mar 31, 2024 14.00 Mn
Dec 31, 2023 118.00 Mn
Sep 30, 2023 11.00 Mn
Jun 30, 2023 14.00 Mn
Mar 31, 2023 14.00 Mn
Dec 31, 2022 117.00 Mn
Sep 30, 2022 10.00 Mn
Jun 30, 2022 10.00 Mn
Mar 31, 2022 103.00 Mn
Dec 31, 2021 53.00 Mn